Cargando…

A lipid metabolism–based prognostic risk model for HBV–related hepatocellular carcinoma

BACKGROUND: Up to 85% of hepatocellular carcinoma (HCC) cases in China can be attributed to infection of hepatitis B virus (HBV). Lipid metabolism performs important function in hepatocarcinogenesis of HBV–related liver carcinoma. However, limited studies have explored the prognostic role of lipid m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Lili, Xia, Shaohuai, Liu, Yaoyao, Ji, Qiang, Li, Lifeng, Gao, Xuan, Guo, Xiaodi, Yi, Xin, Chen, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067291/ https://www.ncbi.nlm.nih.gov/pubmed/37004044 http://dx.doi.org/10.1186/s12944-023-01780-9

Ejemplares similares

Prognostic Role of ceRNA Network in Immune Infiltration of Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma
por: Ma, Keqiang, et al.
Publicado: (2023)

Immunological Significance of Prognostic DNA Methylation Sites in Hepatocellular Carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The Intracellular HBV DNAs as Novel and Sensitive Biomarkers for the Clinical Diagnosis of Occult HBV Infection in HBeAg Negative Hepatocellular Carcinoma in China
por: Wang, Hui, et al.
Publicado: (2014)

Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

The diagnostic and prognostic implications of PRKRA expression in HBV-related hepatocellular carcinoma
por: Hu, Yi-Min, et al.
Publicado: (2022)

Prognostic value of preoperative computed tomography in HBV-related hepatocellular carcinoma patients after curative resection
por: Zhang, Wei, et al.
Publicado: (2019)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

Serum microRNA profiles as prognostic biomarkers for HBV-positive hepatocellular carcinoma
por: Zhu, Hao-Tu, et al.
Publicado: (2016)

Prognostic factors in patients with HBV-related hepatocellular carcinoma following hepatic resection
por: Rungsakulkij, Narongsak, et al.
Publicado: (2018)

The Mechanisms of HBV-Induced Hepatocellular Carcinoma
por: Jiang, Yu, et al.
Publicado: (2021)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2022)

Prognostic value of postoperative change in liver stiffness in patients with HBV-related hepatocellular carcinoma
por: Liu, Youde, et al.
Publicado: (2020)

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
por: Zheng, Ye, et al.
Publicado: (2022)

The HBV Specially-Related Long Noncoding RNA HBV-SRL Involved in the Pathogenesis of Hepatocellular Carcinoma
por: Zhang, Cunzhen, et al.
Publicado: (2022)

Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma
por: Gao, Zhenfu, et al.
Publicado: (2022)

Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma
por: Wang, Xin, et al.
Publicado: (2019)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma
por: Shang, Liming, et al.
Publicado: (2017)

Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma
por: Hong, Ying-Fen, et al.
Publicado: (2017)

Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017)

Update Treatment for HBV Infection and Persistent Risk for Hepatocellular Carcinoma: Prospect for an HBV Cure
por: Yoo, Joseph, et al.
Publicado: (2018)

Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
por: Tantiwetrueangdet, Anchalee, et al.
Publicado: (2018)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
por: Zhao, Ling-Hao, et al.
Publicado: (2016)

Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma
por: Zhang, Weilu, et al.
Publicado: (2020)

Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea
por: Peng, Lu, et al.
Publicado: (2021)

Sparse logistic regression revealed the associations between HBV PreS quasispecies and hepatocellular carcinoma
por: Jia, Jian-an, et al.
Publicado: (2022)

Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma
por: Li, Yuwei, et al.
Publicado: (2019)

The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
por: Yu, Liang-He, et al.
Publicado: (2011)

Lactate dehydrogenase is a prognostic indicator in patients with hepatocellular carcinoma treated by sorafenib: results from the real life practice in HBV endemic area
por: Li, Mu-xing, et al.
Publicado: (2016)

Frequency of hepatic HBV-DNA in patients with cirrhosis and hepatocellular carcinoma: relation to serum HBV markers.
por: White, Y. S., et al.
Publicado: (1990)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients
por: Thi Cam Huong, Nguyen, et al.
Publicado: (2022)

Germline Variants and Genetic Interactions of Several EMT Regulatory Genes Increase the Risk of HBV-Related Hepatocellular Carcinoma
por: Liu, Wen-Xuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r31m9doilpnjtr0vju77mmmg4o